title: Divergent mechanisms of paraquat, MPP+, and rotenone toxicity: oxidation of thioredoxin and caspase-3 activation.
abstract: Paraquat, N-methyl-4-phenyl-1,2,3,6 tetrahydropyridine, and rotenone have been shown to reproduce several features of Parkinson's disease in animal and cell culture models. Although these chemicals are known to perturb dopamine homeostasis and induce dopaminergic cell death, their molecular mechanisms of action are not well defined. We have previously shown that paraquat does not require functional dopamine transporter and does not inhibit mitochondrial complex I in order to mediate its toxic action (Richardson et al., 2005). In this study, we show that paraquat specifically oxidized the cytosolic form of thioredoxin and activated Jun N-terminal kinase (JNK), followed by caspase-3 activation. Conversely, 1-methyl-4-phenylpyridinium (MPP(+)) and rotenone oxidized the mitochondrial form of thioredoxin but did not activate JNK-mitogen-activated protein kinase and caspase-3. Loading cells with exogenous dopamine did not exacerbate the toxicity of any of these compounds. These data suggest that oxidative modification of cytosolic proteins is critical to paraquat toxicity, while oxidation of mitochondrial proteins is important for MPP(+) and rotenone toxicity. In addition, intracellular dopamine does not seem to exacerbate the toxicity of these dopaminergic neurotoxicants in this model.
authors.affiliation: Center for Neurodegenerative Disease, School of Medicine, Emory University, Atlanta, Georgia 30322, USA.
authors.forename: Sampath
authors.initials: S
authors.lastname: Ramachandiran
authors.forename: Jason M
authors.initials: JM
authors.lastname: Hansen
authors.forename: Dean P
authors.initials: DP
authors.lastname: Jones
authors.forename: Jason R
authors.initials: JR
authors.lastname: Richardson
authors.forename: Gary W
authors.initials: GW
authors.lastname: Miller
mesh_terms: D015655:1-Methyl-4-phenylpyridinium / Q000633:toxicity*; D000818:Animals; D017209:Apoptosis / Q000187:drug effects; D053148:Caspase 3 / Q000378:metabolism*; D045744:Cell Line, Tumor; D002470:Cell Survival / Q000187:drug effects; D004298:Dopamine / Q000378:metabolism; D050483:Dopamine Plasma Membrane Transport Proteins / Q000235:genetics / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D004789:Enzyme Activation / Q000187:drug effects; D006540:Herbicides / Q000633:toxicity*; D006801:Humans; D007306:Insecticides / Q000633:toxicity*; D048031:JNK Mitogen-Activated Protein Kinases / Q000378:metabolism; D024101:Mitochondrial Proteins / Q000378:metabolism; D009474:Neurons / Q000187:drug effects* / Q000378:metabolism; D010084:Oxidation-Reduction; D010269:Paraquat / Q000633:toxicity*; D020734:Parkinsonian Disorders / Q000139:chemically induced / Q000378:metabolism; D012402:Rotenone / Q000633:toxicity*; D013879:Thioredoxins / Q000378:metabolism*; D014162:Transfection
chemical_list: D050483:Dopamine Plasma Membrane Transport Proteins; D006540:Herbicides; D007306:Insecticides; D024101:Mitochondrial Proteins; C491203:TXN protein, human; C467002:TXN2 protein, human; D012402:Rotenone; D013879:Thioredoxins; D048031:JNK Mitogen-Activated Protein Kinases; D053148:Caspase 3; D010269:Paraquat; D015655:1-Methyl-4-phenylpyridinium; D004298:Dopamine